Notice General Meeting of Shareholders – Sopharma Properties REIT-Sofia (SFI)
Company: Sopharma Properties REIT-Sofia (SFI)
Aval In AD received information that Sopharma Properties REIT appointed a regular General Meeting of Shareholders on 16 June 2022 at 11:00 am in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, ground floor, Hall 3, under the following agenda:
– Report of the managing bodies on the company’s activity in 2021
– Adoption of the 2021 annual financial report of the company
– Report of the registered auditor on the 2021 audit
– Report of the Audit Committee on 2021
– Report of the Investor Relations Director on 2021
– Report on the implementation of the remuneration policy for the members of the managing bodies
– Release from liability of the members of the managing bodies for their activity in 2021
– Election of a registered auditor for 2022
– Financial result allocation decision
Draft resolution: Allocation of the 2021 profit of the company of BGN 9,070,640.40 and after transformation under Art. 29 of the Special Investment Purpose Companies Act amounting to BGN 4,002,713.23 as follows:
1. Gross dividend distribution to the shareholders of BGN 3,643,919.12 in terms of BGN 0.166 gross dividend per share
2. Allocation of the profit remaining after the dividend distribution to the extension of BGN 5,426,721.28 to the retained profit
– Adoption of a decision under Art. 50 (2) of the company’s Statutes
– Fixing the 2022 remuneration to the members of the Board of Directors
– Change of the remuneration to the Audit Committee members
– Adoption of a justification report of the Board of Directors pursuant to Art. 114a (1) of the POSA on the expedience and terms of the rental of immovable properties owned by Sopharma Properties REIT to Sopharma AD as a tenant
– Authorisation of the Board of Directors to make a deal under Art. 114 (1), item 1 of the POSA in accordance with the justification report concerning the rental of immovable properties owned by Sopharma Properties REIT to Sopharma AD as a tenant under the terms and conditions detailed in the GMS invitation
– Adoption of a justification report of the Board of Directors pursuant to Art. 114a (1) of the POSA on the expedience and terms of the rental of immovable properties owned by Sopharma Properties REIT to companies of the group of Sopharma Trading AD as tenants
– Authorisation of the Board of Directors to make a deal under Art. 114 (1), item 1 of the POSA in accordance with the justification report concerning the rental of an immovable property owned by Sopharma Properties REIT to a company of the group of Sopharma Trading AD as a tenant under the terms and conditions detailed in the GMS invitation
– Authorisation of the Board of Directors to make a deal under Art. 114 (1), item 1 of the POSA in accordance with the justification report concerning the rental of immovable properties owned by Sopharma Properties REIT to a company of the group of Sopharma Trading AD as a tenant under the terms and conditions detailed in the GMS invitation
– In the absence of a quorum, the GMS will take place on 01 July 2022 at 11:00 am, at the same place and under the same agenda.
The voting right will be entitled to all shareholders registered with the central securities register fourteen (14) days before the GMS, i.e. by 02 June 2022 (Record Date).
The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the GMS, will be 31 May 2022 (Ex Date: 01 June 2022).
The invitation is available on the website of the Exchange.
The entire piece of news is published on the financial website X3News.
